Jennifer R. Brown, MD, PhD¹, John F. Seymour, MBBS, PhD², Wojciech Jurczak, MD, PhD³, Andrew Aw, MD^4*, Malgorzata Wach, MD^5*, Arpad Illes, MD^6*, Alessandra Tedeschi, MD^7*, Carolyn Owen, MD⁸, Alan P Skarbnik, MD⁹, Daniel Lysak, MD^10*, Ki-Seong Eom, MD, PhD^11*, Martin Šimkovič, MD^12*, Miguel Arturo Pavlovsky, MD¹³, Arnon P. Kater, MD, PhD¹⁴, Barbara F. Eichhorst, MD¹⁵, Kara Miller, MS^16*, Veerendra Munugalavadla, PhD¹⁶, Ting Yu, MD¹⁶, Marianne de Borja, MS^17* and Paolo Ghia, MD, PhD^18,19

¹Dana-Farber Cancer Institute, Boston, MA
²Peter MacCallum Cancer Centre, Royal Melbourne Hospital, The University of Melbourne, Melbourne, VIC, Australia
³Maria Sklodowska-Curie National Institute of Oncology, Kraków, Poland
⁴University of Ottawa, Ottawa, ON, Canada
⁵Medical University of Lublin, Lublin, Poland
⁶University of Debrecen, Debrecen, Hungary
⁷ASST Grande Ospedale Metropolitano Niguarda, Niguarda Cancer Center, Milano, Italy
⁸University of Calgary and Foothills Medical Centre, Calgary, Canada
⁹Novant Health Cancer Institute, Charlotte, NC
¹⁰Fakultní Nemocnice Plzen, Pilsen, Czech Republic
¹¹Department of Hematology, Catholic Hematology Hospital, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea, Republic of (South)
¹²Hradec Králové, University Hospital and Charles University in Prague, Hradec Kralove, Czech Republic
¹³FUNDALEU, Clinical Research Center, Buenos Aires, Argentina
¹⁴Amsterdam University Medical Center, Amsterdam, on behalf of HOVON, Netherlands
¹⁵University Hospital Cologne, Cologne, Germany
¹⁶AstraZeneca, South San Francisco, CA
¹⁷AstraZeneca, Mississauga, Canada
¹⁸Università Vita-Salute San Raffaele, Milano, Italy
¹⁹IRCCS Ospedale San Raffaele, Milano, Italy

Lindsey Roeker, MD¹, Anthony R. Mato, MD^2*, Andrew D. Zelenetz, MD, PhD³, Jae H. Park, MD⁴, Mark Blaine Geyer, MD¹, Andriy Derkach, PhD^5*, David Nemirovsky^5*, Prioty Islam, MD^1*, Lorenzo Falchi, MD⁶, Maria Lia Palomba, MD³, Anita Kumar, MD³, Gilles Salles, MD, PhD³, Jennifer Kimberly Lue, MD³, Aaron D. Goldberg⁷, Deborah M. Stephens, DO⁸, Victoria Duffy^6*, Gail Panton^6*, Dianna Tyznar^6*, Colleen Dorsey^6*, Dhara Soni^6*, Claire Hutzler^6*, Lauren Nogan^6*, Alexandra Allen^6*, Tenzin Nyima^6*, Thu Quynh Nguyen, BSc^9*, Monica Shah, BA^10*, Tamotha R Cook^8*, Jennifer Abillar-Wright^6*, Jamila Brutus, NP^6*, Carissa Laudati, NP^6*, Bejal Kikani^11*, Catherine C Coombs, MD^12*, Michael R. Silvestrone^6*, Christopher E. Jensen^8*, Bita Fakhri, MD, MPH¹³ and Meghan C. Thompson, MD¹

¹Leukemia Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
²Hematology & Oncology, Cayuga Medical Center, Ithaca, NY
³Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
⁴Cell Therapy Service and Leukemia Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
⁵Department of Biostatistics and Epidemiology, Memorial Sloan Kettering Cancer Center, New York, NY
⁶Memorial Sloan Kettering Cancer Center, New York, NY
⁷Department of Medicine; Leukemia Service, Memorial Sloan Kettering Cancer Center, New York, NY
⁸University of North Carolina Chapel Hill, Chapel Hill, NC
⁹Stanford Cancer Institute, Palo Alto, CA
¹⁰Leukemia Service, Memorial Sloan Kettering Cancer Center, New York, NY
¹¹UNC Chapel Hill, Chapel Hill, NC
¹²University of California Irvine Health, Orange, CA
¹³Stanford University School of Medicine, Stanford, CA

Nitin Jain, MD¹, Alessandra Ferrajoli, MD¹, Mahesh Swaminathan, MD¹, Patrick K. Reville, MD, MPH¹, Jan A. Burger, MD, PhD ¹, Vanthana Bharathi, MD^1*, Himachandana Atluri, MD¹, Hua-Jay J Cherng, MD², Alex Bataller, MD, PhD^1*, Elias Jabbour, MD¹, Tapan M. Kadia, MD¹, Gautam Borthakur, MD¹, Koichi Takahashi, MD, PhD¹, Kelly S. Chien, MD¹, Musa Yilmaz, MD^1*, Naveen Pemmaraju, MD¹, Naval Daver, MD¹, Fadi G. Haddad, MD¹, Yesid Alvarado Valero, MD¹, Jo Ishizawa, MD, PhD¹, Guillermo Montalban-Bravo, MD¹, Naveen Garg, MD^3*, Hyunsoo Hwang, MS^4*, Wei Qiao, PhD^4*, Cameron Garcia, RN^1*, Anna Evangelio, RN^1*, Ana Ayala, RN^1*, Deepa Sampath, PhD⁵, Varsha Gandhi, PhD⁶, Michael J. Keating, MBBS¹, Hagop M. Kantarjian, MD¹ and William G. Wierda¹

¹Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
²Division of Hematology & Oncology, Columbia University Irving Medical Center, Long Island City, NY
³Department of Radiology, The University of Texas MD Anderson Cancer Center, Houston, TX
⁴Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX
⁵Department of Hematopoietic Biology and Malignancy, The University of Texas MD Anderson Cancer Center, Houston, TX
⁶Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX

Jacob D. Soumerai, MD¹, Chan Y. Cheah, MBBS DMSc^2,3,4, Mary Ann Anderson, MBBS, PhD, FRACP, FRCPA^5,6*, Masa Lasica, MBBS, BMedSci, FRACP, FRCPA^7*, Emma Verner, MBBS^8,9*, Stephen S. Opat, MBBS, FRACP, FRCPA¹⁰, Shuo Ma, MD, PhD¹¹, Robert Weinkove, MBBS, PhD, FRACP, FRCPath^12,13*, Raul Cordoba, MD, PhD¹⁴, Paolo Ghia, MD, PhD^15,16, Sophie Leitch^17*, David Westerman, MBBS, FRCPA, FRACP^18,19, Sheel Patel^20*, Yiqian Fang^21*, Wei Ding^20*, Haiyi Guo^21* and Constantine S. Tam, MD, MBBS²²

¹Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston, MA
²Sir Charles Gairdner Hospital, Nedlands, Western Australia, Australia
³Medical School, University of Western Australia, Perth, Western Australia, Australia
⁴Linear Clinical Research, Nedlands, Western Australia, Australia
⁵Division of Blood Cells and Blood Cancer, Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia
⁶Centre of Excellence for Cellular Immunotherapy and Clinical Haematology, Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Melbourne, VIC, Australia
⁷St Vincent’s Hospital, Melbourne, Australia
⁸University of Sydney, Sydney, NSW, Australia
⁹Concord Repatriation General Hospital, Concord, NSW, Australia
¹⁰Lymphoma Research Group, School of Clinical Sciences at Monash Health, Monash University, Clayton, VIC, Australia
¹¹Robert H. Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine, Chicago, IL
¹²Te Rerenga Ora Blood and Cancer Centre, Te Whatu Ora Health New Zealand Capital Coast & Hutt Valley, Wellington, New Zealand
¹³Cancer Immunotherapy Programme, Malaghan Institute of Medical Research, Wellington, New Zealand
¹⁴Hospital Universitario Fundación Jiménez Díaz, Madrid, Spain
¹⁵Università Vita-Salute San Raffaele, Milano, Italy
¹⁶IRCCS Ospedale San Raffaele, Milan, Italy
¹⁷Haematology Service, Health New Zealand - Te Whatu Ora - Waitemata, Auckland, New Zealand
¹⁸University of Melbourne, Melbourne, VIC, Australia
¹⁹Department of Pathology, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia
²⁰BeiGene USA, Inc, San Mateo, CA
²¹BeiGene (Shanghai) Co, Ltd, Shanghai, China
²²Alfred Hospital and Monash University, Melbourne, VIC, Australia

Mark-David Levin¹, Sabina Kersting, MD, PhD^2*, Julie Dubois, MD, PhD^3*, Bronno van der Holt, PhD^4,5*, Caspar da Cunha-Bang, MD, PhD^6*, Doreen te Raa, MD, PhD^7*, Cecile Idink, MB, PhD^8*, Fransien De Boer, MD, PhD^9*, Jolanda Droogendijk, MD^10*, Koen de Heer, MD, PhD^11*, Leonie van der Burg, MD^12*, Marten R. Nijziel, MD, PhD¹³, Lidwine Tick, MD, PhD^14*, Henriettte Levenga, MD^15*, Matthijs Silbermann, MD^16*, Inge Ludwig, MD, MSc^17*, Aart Beeker, MD¹⁸, Mar Bellido, MD, PhD^19*, Anne-Marie Van Der Kevie-Kersemaekers, PhD^20*, Clemens Mellink^20*, Ine Meulendijks^4*, Sjoerd Zoun-van den Dool^4*, Martine Abrahamse-Testroote^21*, Gerben Zwezerijnen^22*, Carsten Utoft Niemann, MD, PhD^23* and Arnon P. Kater, MD, PhD²⁴

¹Department of Internal Medicine, Albert Schweitzer Hospital, Dordrecht, Netherlands
²Department of Hematology, Haga Ziekenhuis, Den Haag, Netherlands
³Department of Hematology, University of Amsterdam, Amsterdam, Netherlands
⁴ErasmusMC, Rotterdam, Netherlands
⁵Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, Netherlands
⁶Department of Hematology, Rigshospitalet, Copenhagen, Denmark
⁷Ziekenhuis Gelderse Vallei, Ede, Netherlands
⁸Zorgsaam, Terneuzen, NLD
⁹Ikazia Hospital, Rotterdam, Netherlands
¹⁰Elisabeth Tweesteden ziekenhuis, Tilburg, NLD
¹¹Department of Internal Medicine, Flevoziekenhuis, Almere, Netherlands
¹²Antonius ziekenhuis, Sneek, Netherlands
¹³Maxima Medical Center Eindhoven/Veldhoven, Eindhoven, Noord-Brabant, NLD
¹⁴Maxima Medisch Centrum, Eindhoven, Netherlands
¹⁵Groene Hart ziekenhuis, Gouda, Netherlands
¹⁶Ter Gooi ziekenhuis, XZ HILVERSUM, NLD
¹⁷Department of Hematology, Bernhoven Hospital, Uden, Netherlands
¹⁸Spaarne Ziekenhuis, Hoofddorp, Netherlands
¹⁹University Medical Center Groningen and University of Groningen, Groningen, Netherlands
²⁰AmsterdamUMC, Amsterdam, NLD
²¹ErasmusMC, Rotterdam, NLD
²²Cancer Center Amsterdam, Amsterdam UMC Radiology and Nuclear Medicine, Amsterdam, Netherlands
²³Department of Hematology, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark
²⁴Amsterdam University Medical Center, Amsterdam, on behalf of HOVON, Netherlands

Patrick K. Reville, MD, MPH¹, Sogand Sajedi, PhD¹, Alessandra Ferrajoli, MD¹, Jan A. Burger, MD, PhD ¹, Michael J. Keating, MBBS¹, Naveen Garg, MD^2*, Qing Deng, PhD^3*, Michael R. Green, PhD⁴, Hussein A. Abbas, MD, PhD¹, William G. Wierda¹ and Nitin Jain, MD¹

¹Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
²Department of Radiology, The University of Texas MD Anderson Cancer Center, Houston, TX
³Department of Lymphoma & Myeloma, The University of Texas at MD Anderson Cancer, Houston, TX
⁴Department of Lymphoma & Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX